Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 344 entries
Sorted by: Best Match Show Resources per page
Erratum to: The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology.

Rheumatology international

Migliore A, Scirè CA, Carmona L, Herrero-Beaumont G, Bizzi E, Branco J, Carrara G, Chevalier X, Collaku L, Aslanidis S, Denisov L, Di Matteo L, Bianchi G, Diracoglu D, Frediani B, Maheu E, Martusevich N, Bagnato GF, Scarpellini M, Minisola G, Akkoc N, Ramonda R, Barskova T, Babic-Naglic D, Muelas JVM, Ionescu R, Rashkov R, Damjanov N, Cerinic MM.
PMID: 28523419
Rheumatol Int. 2017 Aug;37(8):1237-1238. doi: 10.1007/s00296-017-3742-1.

No abstract available.

Cite
Migliore A, Scirè CA, Carmona L, et al. Erratum to: The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology. Rheumatol Int. 2017;37(8):1237-1238doi: 10.1007/s00296-017-3742-1.
Migliore, A., Scirè, C. A., Carmona, L., Herrero-Beaumont, G., Bizzi, E., Branco, J., Carrara, G., Chevalier, X., Collaku, L., Aslanidis, S., Denisov, L., Di Matteo, L., Bianchi, G., Diracoglu, D., Frediani, B., Maheu, E., Martusevich, N., Bagnato, G. F., Scarpellini, M., Minisola, G., Akkoc, N., Ramonda, R., Barskova, T., Babic-Naglic, D., Muelas, J. V. M., Ionescu, R., Rashkov, R., Damjanov, N., & Cerinic, M. M. (2017). Erratum to: The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology. Rheumatology international, 37(8), 1237-1238. https://doi.org/10.1007/s00296-017-3742-1
Migliore, Alberto, et al. "Erratum to: The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology." Rheumatology international vol. 37,8 (2017): 1237-1238. doi: https://doi.org/10.1007/s00296-017-3742-1
Migliore A, Scirè CA, Carmona L, Herrero-Beaumont G, Bizzi E, Branco J, Carrara G, Chevalier X, Collaku L, Aslanidis S, Denisov L, Di Matteo L, Bianchi G, Diracoglu D, Frediani B, Maheu E, Martusevich N, Bagnato GF, Scarpellini M, Minisola G, Akkoc N, Ramonda R, Barskova T, Babic-Naglic D, Muelas JVM, Ionescu R, Rashkov R, Damjanov N, Cerinic MM. Erratum to: The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology. Rheumatol Int. 2017 Aug;37(8):1237-1238. doi: 10.1007/s00296-017-3742-1. PMID: 28523419.
Copy Download .nbib Format: NLM
Erratum to: Bone density in proton pump inhibitors users: a prospective study.

Rheumatology international

Ozdil K, Kahraman R, Sahin A, Calhan T, Gozden EH, Akyuz U, Erer B, Sokmen MH.
PMID: 27553689
Rheumatol Int. 2016 Oct;36(10):1479. doi: 10.1007/s00296-016-3554-8.

No abstract available.

Cite
Ozdil K, Kahraman R, Sahin A, et al. Erratum to: Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int. 2016;36(10):1479doi: 10.1007/s00296-016-3554-8.
Ozdil, K., Kahraman, R., Sahin, A., Calhan, T., Gozden, E. H., Akyuz, U., Erer, B., & Sokmen, M. H. (2016). Erratum to: Bone density in proton pump inhibitors users: a prospective study. Rheumatology international, 36(10), 1479. https://doi.org/10.1007/s00296-016-3554-8
Ozdil, Kamil, et al. "Erratum to: Bone density in proton pump inhibitors users: a prospective study." Rheumatology international vol. 36,10 (2016): 1479. doi: https://doi.org/10.1007/s00296-016-3554-8
Ozdil K, Kahraman R, Sahin A, Calhan T, Gozden EH, Akyuz U, Erer B, Sokmen MH. Erratum to: Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int. 2016 Oct;36(10):1479. doi: 10.1007/s00296-016-3554-8. PMID: 27553689.
Copy Download .nbib Format: NLM
Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.

Rheumatology international

Castrejon I, Toledano E, Rosario MP, Loza E, Pérez-Ruiz F, Carmona L.
PMID: 25895647
Rheumatol Int. 2015 Jul;35(7):1139. doi: 10.1007/s00296-015-3264-7.

No abstract available.

Cite
Castrejon I, Toledano E, Rosario MP, et al. Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatol Int. 2015;35(7):1139doi: 10.1007/s00296-015-3264-7.
Castrejon, I., Toledano, E., Rosario, M. P., Loza, E., Pérez-Ruiz, F., & Carmona, L. (2015). Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatology international, 35(7), 1139. https://doi.org/10.1007/s00296-015-3264-7
Castrejon, Isabel, et al. "Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis." Rheumatology international vol. 35,7 (2015): 1139. doi: https://doi.org/10.1007/s00296-015-3264-7
Castrejon I, Toledano E, Rosario MP, Loza E, Pérez-Ruiz F, Carmona L. Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatol Int. 2015 Jul;35(7):1139. doi: 10.1007/s00296-015-3264-7. PMID: 25895647.
Copy Download .nbib Format: NLM
Retracted article: Systemic sclerosis and malignancies after cyclophosphamide therapy: a single center experience.

Rheumatology international

[No authors listed]
PMID: 22190276
Rheumatol Int. 2012 Apr;32(4):1111. doi: 10.1007/s00296-011-2321-0. Epub 2011 Dec 22.

No abstract available.

Cite
Retracted article: Systemic sclerosis and malignancies after cyclophosphamide therapy: a single center experience. Rheumatol Int. 2011;32(4):1111doi: 10.1007/s00296-011-2321-0.
(2012). Retracted article: Systemic sclerosis and malignancies after cyclophosphamide therapy: a single center experience. Rheumatology international, 32(4), 1111. https://doi.org/10.1007/s00296-011-2321-0
"Retracted article: Systemic sclerosis and malignancies after cyclophosphamide therapy: a single center experience." Rheumatology international vol. 32,4 (2012): 1111. doi: https://doi.org/10.1007/s00296-011-2321-0
Retracted article: Systemic sclerosis and malignancies after cyclophosphamide therapy: a single center experience. Rheumatol Int. 2012 Apr;32(4):1111. doi: 10.1007/s00296-011-2321-0. Epub 2011 Dec 22. PMID: 22190276.
Copy Download .nbib Format: NLM
Correction to: Systemic vasculitis involving the breast: a case report and literature review.

Rheumatology international

Ren J, Liu J, Su J, Zhang J, Zhao J.
PMID: 30972542
Rheumatol Int. 2019 Aug;39(8):1457. doi: 10.1007/s00296-019-04294-9.

The article "Systemic vasculitis involving the breast: a case report and literature review" written by Jinxia Zhao, was originally published electronically on the publisher's internet portal (currently SpringerLink) on March 14, 2019 with open access. With the author(s) decision...

Cite
Ren J, Liu J, Su J, et al. Correction to: Systemic vasculitis involving the breast: a case report and literature review. Rheumatol Int. 2019;39(8):1457doi: 10.1007/s00296-019-04294-9.
Ren, J., Liu, J., Su, J., Zhang, J., & Zhao, J. (2019). Correction to: Systemic vasculitis involving the breast: a case report and literature review. Rheumatology international, 39(8), 1457. https://doi.org/10.1007/s00296-019-04294-9
Ren, Jiaqi, et al. "Correction to: Systemic vasculitis involving the breast: a case report and literature review." Rheumatology international vol. 39,8 (2019): 1457. doi: https://doi.org/10.1007/s00296-019-04294-9
Ren J, Liu J, Su J, Zhang J, Zhao J. Correction to: Systemic vasculitis involving the breast: a case report and literature review. Rheumatol Int. 2019 Aug;39(8):1457. doi: 10.1007/s00296-019-04294-9. PMID: 30972542.
Copy Download .nbib Format: NLM
Implement statistics at each step of your research.

Rheumatology international

Coskun Benlidayi I.
PMID: 31111292
Rheumatol Int. 2019 Jul;39(7):1303-1304. doi: 10.1007/s00296-019-04327-3. Epub 2019 May 20.

No abstract available.

Cite
Coskun Benlidayi I. Implement statistics at each step of your research. Rheumatol Int. 2019;39(7):1303-1304doi: 10.1007/s00296-019-04327-3.
Coskun Benlidayi, I. (2019). Implement statistics at each step of your research. Rheumatology international, 39(7), 1303-1304. https://doi.org/10.1007/s00296-019-04327-3
Coskun Benlidayi, Ilke. "Implement statistics at each step of your research." Rheumatology international vol. 39,7 (2019): 1303-1304. doi: https://doi.org/10.1007/s00296-019-04327-3
Coskun Benlidayi I. Implement statistics at each step of your research. Rheumatol Int. 2019 Jul;39(7):1303-1304. doi: 10.1007/s00296-019-04327-3. Epub 2019 May 20. PMID: 31111292.
Copy Download .nbib Format: NLM
Family history of ochronotic arthropathy.

Rheumatology international

Gómez-Lechón Quirós L, Hidalgo Calleja C, Acosta de la Vega ME, Compán Fernández O, Pastor Navarro S, Montilla Morales C.
PMID: 32642830
Rheumatol Int. 2021 Oct;41(10):1869-1874. doi: 10.1007/s00296-020-04640-2. Epub 2020 Jul 08.

Alkaptonuria is a rare autosomal-recessive disorder that produces accumulation of homogentisic acid in body fluids. The accumulation in collagen tissues, mainly in the joint cartilage, produces ochronotic arthropathy. We report two clinical cases of one brother and sister with...

Cite
Gómez-Lechón Quirós L, Hidalgo Calleja C, Acosta de la Vega ME, et al. Family history of ochronotic arthropathy. Rheumatol Int. 2020;41(10):1869-1874doi: 10.1007/s00296-020-04640-2.
Gómez-Lechón Quirós, L., Hidalgo Calleja, C., Acosta de la Vega, M. E., Compán Fernández, O., Pastor Navarro, S., & Montilla Morales, C. (2021). Family history of ochronotic arthropathy. Rheumatology international, 41(10), 1869-1874. https://doi.org/10.1007/s00296-020-04640-2
Gómez-Lechón Quirós, L, et al. "Family history of ochronotic arthropathy." Rheumatology international vol. 41,10 (2021): 1869-1874. doi: https://doi.org/10.1007/s00296-020-04640-2
Gómez-Lechón Quirós L, Hidalgo Calleja C, Acosta de la Vega ME, Compán Fernández O, Pastor Navarro S, Montilla Morales C. Family history of ochronotic arthropathy. Rheumatol Int. 2021 Oct;41(10):1869-1874. doi: 10.1007/s00296-020-04640-2. Epub 2020 Jul 08. PMID: 32642830.
Copy Download .nbib Format: NLM
Correction to: IgG4 sclerosing disease of the esophagus: a case‑based review.

Rheumatology international

Padniewski JJ, Thottam GE, Nasr R.
PMID: 32666136
Rheumatol Int. 2020 Oct;40(10):1739. doi: 10.1007/s00296-020-04647-9.

In the original article published, the name of the second author is incorrect.

Cite
Padniewski JJ, Thottam GE, Nasr R. Correction to: IgG4 sclerosing disease of the esophagus: a case‑based review. Rheumatol Int. 2020;40(10):1739doi: 10.1007/s00296-020-04647-9.
Padniewski, J. J., Thottam, G. E., & Nasr, R. (2020). Correction to: IgG4 sclerosing disease of the esophagus: a case‑based review. Rheumatology international, 40(10), 1739. https://doi.org/10.1007/s00296-020-04647-9
Padniewski, Jessica Joanne, et al. "Correction to: IgG4 sclerosing disease of the esophagus: a case‑based review." Rheumatology international vol. 40,10 (2020): 1739. doi: https://doi.org/10.1007/s00296-020-04647-9
Padniewski JJ, Thottam GE, Nasr R. Correction to: IgG4 sclerosing disease of the esophagus: a case‑based review. Rheumatol Int. 2020 Oct;40(10):1739. doi: 10.1007/s00296-020-04647-9. PMID: 32666136.
Copy Download .nbib Format: NLM
Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis.

Rheumatology international

Kancharla H, Jain S, Mishra S, Acharya N, Grover S, Dogra S, Sharma A.
PMID: 34251497
Rheumatol Int. 2021 Jul 12; doi: 10.1007/s00296-021-04925-0. Epub 2021 Jul 12.

Fibromyalgia syndrome (FMS) is common in patients of psoriatic arthritis (PsA), but the magnitude of its impact is uncertain. This cross-sectional study evaluated the impact of FMS on health-related quality of life (HRQoL) and disease activity in PsA. Adults...

Cite
Kancharla H, Jain S, Mishra S, et al. Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis. Rheumatol Int. 2021;doi: 10.1007/s00296-021-04925-0.
Kancharla, H., Jain, S., Mishra, S., Acharya, N., Grover, S., Dogra, S., & Sharma, A. (2021). Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis. Rheumatology international, . https://doi.org/10.1007/s00296-021-04925-0
Kancharla, Harish, et al. "Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-04925-0
Kancharla H, Jain S, Mishra S, Acharya N, Grover S, Dogra S, Sharma A. Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis. Rheumatol Int. 2021 Jul 12; doi: 10.1007/s00296-021-04925-0. Epub 2021 Jul 12. PMID: 34251497.
Copy Download .nbib Format: NLM
Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus.

Rheumatology international

Muhammed H, Jain A, Pattanaik SS, Chatterjee R, Naveen R, Kabeer H, Gupta L, Misra DP, Agarwal V, Lawrence A, Misra R, Aggarwal A.
PMID: 34191047
Rheumatol Int. 2021 Dec;41(12):2185-2193. doi: 10.1007/s00296-021-04933-0. Epub 2021 Jun 30.

INTRODUCTION: There is paucity of data on tuberculosis in Indian patients with systemic lupus erythematosus (SLE). We retrospectively studied clinical features and outcome of tuberculosis in SLE.METHODS: Medical records of patients who developed tuberculosis simultaneous or after the diagnosis...

Cite
Muhammed H, Jain A, Pattanaik SS, et al. Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus. Rheumatol Int. 2021;41(12):2185-2193doi: 10.1007/s00296-021-04933-0.
Muhammed, H., Jain, A., Pattanaik, S. S., Chatterjee, R., Naveen, R., Kabeer, H., Gupta, L., Misra, D. P., Agarwal, V., Lawrence, A., Misra, R., & Aggarwal, A. (2021). Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus. Rheumatology international, 41(12), 2185-2193. https://doi.org/10.1007/s00296-021-04933-0
Muhammed, Hafis, et al. "Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus." Rheumatology international vol. 41,12 (2021): 2185-2193. doi: https://doi.org/10.1007/s00296-021-04933-0
Muhammed H, Jain A, Pattanaik SS, Chatterjee R, Naveen R, Kabeer H, Gupta L, Misra DP, Agarwal V, Lawrence A, Misra R, Aggarwal A. Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus. Rheumatol Int. 2021 Dec;41(12):2185-2193. doi: 10.1007/s00296-021-04933-0. Epub 2021 Jun 30. PMID: 34191047.
Copy Download .nbib Format: NLM
A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls.

Rheumatology international

Ince B, Kamali S, Bektaş M, Ögret YD, Savran FO, Yalçinkaya Y, Artim-Esen B, Inanç M, Öcal L, Gül A.
PMID: 33544216
Rheumatol Int. 2021 Sep;41(9):1667-1672. doi: 10.1007/s00296-021-04789-4. Epub 2021 Feb 05.

We aimed to analyse the distribution of HLA Class 2 genotypes which were reported among the genetic risk factors for ANCA-associated vasculitis (AAV) among Turkish patients in comparison with healthy subjects and previously reported data of AAV cohorts. Ninety-eight...

Cite
Ince B, Kamali S, Bektaş M, et al. A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls. Rheumatol Int. 2021;41(9):1667-1672doi: 10.1007/s00296-021-04789-4.
Ince, B., Kamali, S., Bektaş, M., Ögret, Y. D., Savran, F. O., Yalçinkaya, Y., Artim-Esen, B., Inanç, M., Öcal, L., & Gül, A. (2021). A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls. Rheumatology international, 41(9), 1667-1672. https://doi.org/10.1007/s00296-021-04789-4
Ince, Burak, et al. "A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls." Rheumatology international vol. 41,9 (2021): 1667-1672. doi: https://doi.org/10.1007/s00296-021-04789-4
Ince B, Kamali S, Bektaş M, Ögret YD, Savran FO, Yalçinkaya Y, Artim-Esen B, Inanç M, Öcal L, Gül A. A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls. Rheumatol Int. 2021 Sep;41(9):1667-1672. doi: 10.1007/s00296-021-04789-4. Epub 2021 Feb 05. PMID: 33544216.
Copy Download .nbib Format: NLM
Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically inactive disease: a single-centre retrospective evaluation.

Rheumatology international

Gargh K, Al-Abadi E, Low S, Harrison K, Coles W, Davis P, Johnson K.
PMID: 34796407
Rheumatol Int. 2021 Nov 18; doi: 10.1007/s00296-021-05049-1. Epub 2021 Nov 18.

The Paediatric Rheumatology International Trials Organisation (PRINTO) criteria for clinically inactive disease (CID) and their proposal for glucocorticoid tapering do not consider MRI findings, despite the growing use of MRI and development of reliable MRI scoring tools. We aim...

Cite
Gargh K, Al-Abadi E, Low S, et al. Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically inactive disease: a single-centre retrospective evaluation. Rheumatol Int. 2021;doi: 10.1007/s00296-021-05049-1.
Gargh, K., Al-Abadi, E., Low, S., Harrison, K., Coles, W., Davis, P., & Johnson, K. (2021). Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically inactive disease: a single-centre retrospective evaluation. Rheumatology international, . https://doi.org/10.1007/s00296-021-05049-1
Gargh, Kapil, et al. "Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically inactive disease: a single-centre retrospective evaluation." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-05049-1
Gargh K, Al-Abadi E, Low S, Harrison K, Coles W, Davis P, Johnson K. Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically inactive disease: a single-centre retrospective evaluation. Rheumatol Int. 2021 Nov 18; doi: 10.1007/s00296-021-05049-1. Epub 2021 Nov 18. PMID: 34796407.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 344 entries